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Summary
 
Cataract, already a major cause of visual impairment and blindness, is likely to become an in-
creasing problem as the world population ages. In a previous study, we showed that transform-
ing growth factor-
 
b
 
 (TGF
 
b
 
) induces rat lenses in culture to develop opacities and other
changes that have many features of human subcapsular cataracts. Here we show that estrogen
protects against cataract. Lenses from female rats are more resistant to TGF
 
b
 
-induced cataract
than those from males. Furthermore, lenses from ovariectomized females show increased sen-
sitivity to the damaging effects of TGF
 
b
 
 and estrogen replacement in vivo, or exposure to es-
trogen in vitro, restores resistance. Sex-dependent and estrogen-related differences in suscepti-
bility to cataract formation, consistent with a protective role for estrogen, have been noted in
some epidemiological studies. The present study in the rat indicates that estrogen provides pro-
tection against cataract by countering the damaging effects of TGF
 
b
 
. It also adds to an increasing
body of evidence that hormone replacement therapy protects postmenopausal women against
various diseases.
 
T
 
he mammalian lens has a highly organized cellular ar-
chitecture. A monolayer of cuboidal epithelial cells
covers the anterior surface of the elongated fiber cells that
constitute the bulk of the lens. These cellular elements are
enclosed within a thickened basement membrane, the lens
capsule. Normally, the lens transmits light and focuses it onto
the retina. Cataract, or clouding of the ocular lens, is asso-
ciated with disruption of normal cellular architecture. This
condition is a major cause of visual impairment and is likely
to become an even greater public health problem as the
world population ages. Predisposing factors include aging, dia-
betes, UV/sunlight, ocular surgery, and malnutrition (1).
A role for female hormones in protecting against cataract
has been suggested by recent epidemiological studies. The
prevalence of cataract increases in postmenopausal women
(2, 3). Moreover, postmenopausal women on hormone re-
placement therapy or younger women taking oral contracep-
tives display a decreased prevalence and severity of cataract
(4–7).
We have developed a lens culture system for investigat-
ing cataractogenesis and factors that influence it. Using this
system, we have shown that transforming growth factor-
 
b
 
(TGF
 
b
 
) induces responses in lens cells that mimic events in
cataractogenesis. Rat lens epithelial explants (8, 9) and lenses
(10) cultured with TGF
 
b
 
 undergo molecular and morpho-
logical changes that are typically associated with anterior
subcapsular cataract and with the subcapsular opacification that
often arises from cells left behind after cataract surgery (af-
tercataract). Some of these changes are also known to be as-
sociated with posterior subcapsular cataract. It is significant
that TGF
 
b
 
 induces distinct anterior subcapsular opacities in
cultured rat lenses (10). Histologically, these correspond with
subcapsular plaques of aberrant cells which are virtually in-
distinguishable from early stage anterior subcapsular cata-
racts in humans (see reference 11). Two molecular markers
for subcapsular cataract, 
 
a
 
-smooth muscle actin and type I
collagen, are also present. The finding that TGF
 
b
 
 is cata-
ractogenic is consistent with many studies which now indicate
that TGF
 
b
 
 is involved in the aetiology of diseases in other
organs (for example see references 12 and 13). These diseases
are generally associated with fibrotic changes.
In the present study, using our lens culture system, we
have shown that lenses from female rats are less susceptible
to the cataractogenic effects of TGF
 
b
 
 than those from
males. In addition, using whole lenses from ovariectomized
rats, we have established that resistance to TGF
 
b
 
-induced
cataract is conferred by estrogen.
 
Materials and Methods
 
17-
 
b
 
-estradiol (1,3,5[10]-Estratriene-3, 17
 
b
 
-diol) and progester-
one (4-Pregnene-3, 20-dione) were obtained from Sigma Chem-
ical Co. (St. Louis, MO) and human recombinant TGF
 
b
 
2 from
Genzyme Corp. (Cambridge, MA). In some experiments, lenses
were derived from normal 6–10-mo-old adult male and female
Wistar rats, killed by CO
 
2
 
 asphyxiation before removal of eyes.
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Alternatively, ovariectomies were performed on 3-mo-old female
Wistar rats under anaesthesia as described elsewhere (14). After
waiting for 4–5 wk to ensure clearance of residual estrogen and
progesterone, ovariectomized rats were given three daily injec-
tions of 0.5 
 
m
 
g 17-
 
b
 
-estradiol or 5 mg progesterone, dissolved in
benzyl alcohol/peanut oil (1:3, vol/vol). Control rats received ve-
hicle alone. 1 d later, rats were sacrificed by a lethal dose of nembutal
(Boehringer Ingelheim, Sydney, Australia) before removal of eyes.
 
Lens Cultures.
 
Lenses were carefully dissected free from sur-
rounding ocular tissues in culture medium, as described previ-
ously (10), and cultured with TGF
 
b
 
2 at final concentrations of
0.025–4 ng/ml, which was added immediately unless otherwise
indicated. Controls received no TGF
 
b
 
. Culture medium was re-
newed every 2 d throughout the culture period, without further
addition of TGF
 
b
 
. Lenses were cultured for 7 d and the anterior
surface was photographed daily to record development of opaci-
ties. At the end of the culture period, lenses were fixed in Car-
noy’s fixative (acetic acid/ethanol, 1:3, vol/vol) and embedded in
paraffin.
Generally, serum-free medium 199 containing antibiotics and
0.1% bovine serum albumin, as already described (10), was used
as culture medium. When testing the effect of estrogen in vitro,
medium 199 was replaced by phenol red-free minimum essential
medium (Sigma Chemical Co.).
 
Opacification Index.
 
TGF
 
b
 
-induced lens opacification begins
as diffuse clouding on the anterior surface of the lens. As the re-
sponse progresses, these regions condense to form distinct opaci-
ties leaving a reduced area of clouding. At low concentrations of
TGF
 
b
 
, few distinct opacities are observed at day 7 of culture, and
a large proportion of the lens surface remains cloudy. In contrast,
most of the initially cloudy areas condense to form numerous dis-
tinct opacities at high concentrations (as in Fig. 1 
 
A
 
). On the basis
of these observations, a method for measuring the extent of
opacification has been developed (15).
Micrographs of lenses at day 7 of culture were used to deter-
mine lens opacification. Each micrograph was scanned with an x-ray
scanner (3CX; XRS Corp., Torrance, CA) using Adobe Photo-
shop and XRS Omni Media software. A series of measurements
was then made using NIH Image v1.52. In some micrographs,
flared reflections of the light source made it impossible to assess
the extent of opacification in certain regions (for example see Fig.
1 
 
B
 
). Only micrographs in which the assessable area represented
 
.
 
75% of the total area were used. The assessable area (
 
A
 
) and,
within this area, the total area of clouding (
 
B
 
), and the total num-
ber of distinct opacities (
 
C
 
), were measured. An “opacification
index” was then calculated as follows:
 
Histology and Immunohistochemistry.
 
Serial sections of paraffin-
embedded lenses were processed for routine histology or for im-
munohistochemical localization of 
 
a
 
-smooth muscle actin or type
I collagen, as already described (10). Representative lenses from
each treatment group were examined by routine histology (all
TGF
 
b
 
2 concentrations) and immunolocalisation (0.15 ng/ml
TGF
 
b
 
2).
 
Results
 
Male–Female Difference in Responsiveness of Lenses to TGF
 
b
 
.
 
Lenses from male rats developed distinct anterior opacities
when cultured with 0.15 ng/ml TGF
 
b
 
2 (Fig. 1 
 
A
 
). In con-
trast, lenses from female rats remained transparent under
these conditions (Fig. 1 
 
B
 
), as did control lenses from male
and female rats cultured without TGF
 
b
 
 (not shown; see
reference 10). However, at a higher concentration of
TGF
 
b
 
2 (1 ng/ml), lenses from female rats also developed
opacities (Table 1). For both sexes, the response increased
significantly with concentration of TGF
 
b
 
.
Histological examination of lenses cultured with 0.15
ng/ml TGF
 
b
 
2 revealed distinct subcapsular plaques, con-
taining spindle-shaped cells and extracellular matrix (see
reference 10) in the lenses from males (not shown). In con-
trast, the lenses from females and controls retained normal
lens architecture, with a monolayer of epithelial cells over-
lying the fiber mass. Immunolocalization of 
 
a
 
-smooth mus-
cle actin and type I collagen showed that, for males, strong
reactivity for both of these cataract markers was present in
plaques induced by culturing with 0.15 ng/ml TGF
 
b
 
2,
whereas corresponding lenses from females showed no re-
activity for 
 
a
 
-smooth muscle actin and only very weak re-
activity for type I collagen in a few cells in the epithelium
Opacification index
number of distinct opacities C ()
proportion of assessable area with clouding BA ¤ ()
------------------------------------------------------------------------------------------------------------------------
=
Figure 1. Comparison of response of
lenses from male and female rats to TGFb.
Lenses were cultured with 0.15 ng/ml
TGFb2 and photographed after 7 d. Lenses
from male rats (A) developed distinct ante-
rior opacities (arrow). Lenses from females
remained transparent (B). Some flaring of
the light source is evident in the upper right-
hand quadrant of each lens. Bar, 400 mm. 
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(not shown). These markers were not detectable in sections
of control lenses from males or females cultured for 
 
<
 
7 d
without TGF
 
b
 
 (not shown).
 
Effect of Hormone Replacement after Ovariectomy on TGF
 
b
 
-
induced Cataract.
 
Having established that lenses from fe-
male rats showed more resistance to the cataractogenic ef-
fects of TGF
 
b
 
 than those from males, ovariectomized rats
were used to assess the contribution of ovarian hormones
to this phenomenon. Lenses from ovariectomized rats
(without hormone replacement) developed opacities when
cultured with 0.15 ng/ml TGF
 
b
 
 (Table 2; Fig. 2 
 
A
 
), a con-
centration shown to have negligible effect on lenses from
normal female rats (Table 1; Fig. 1 
 
B
 
). Lenses from ovariec-
tomized rats which received estrogen, however, did not
develop opacities under these conditions (Table 2; Fig. 2 
 
B
 
),
while the response of lenses from rats treated with proges-
terone was similar to that of lenses from vehicle-treated rats
(Table 2; Fig. 2 
 
C
 
).
Histologically, the opacities observed in ovariectomized
rats that only received vehicle corresponded with subcapsu-
lar plaques or clumps of abnormal cells (Fig. 3 
 
A
 
). Reactiv-
ity for the cataract markers 
 
a
 
-smooth muscle actin and type I
collagen was observed predominantly within the subcapsu-
lar plaques (Fig. 3, 
 
C
 
 and 
 
E
 
). In contrast, lenses from estro-
gen-treated rats retained normal cellular morphology (Fig.
3 
 
B
 
), and no reactivity for 
 
a
 
-smooth muscle actin or type I
collagen was detected (Fig. 3, 
 
D
 
 and 
 
F
 
). In all these re-
spects, lenses from rats that received progesterone replace-
ment were indistinguishable from lenses from rats that re-
ceived vehicle alone.
A variety of more subtle histological changes were ob-
served in lenses from ovariectomized rats that did not re-
ceive estrogen. Swelling of cortical fiber cells with evidence
of degeneration, reminiscent of cortical cataract (11), was
commonly observed (for example see Fig. 3 
 
A
 
), generally
in the region of the lens anterior to the equator. In addi-
tion, nucleated cells were observed migrating along the
 
Table 1.
 
TGF
 
b
 
-induced Opacification in Lenses from Adult Rats
 
TGF
 
b
 
Opacification index
Male Female
 
ng/ml
 
00 0
0.025 13 
 
6
 
 0.3 0
0.15 57 
 
6
 
 50
1 69 
 
6
 
 9 54 
 
6
 
 6
4 187 
 
6
 
 19 118 
 
6
 
 10
 
*
 
Lenses from adult male and female rats were cultured for 7 d. TGF
 
b
 
2
was used at the concentrations indicated. The opacification index was
calculated as described in Materials and Methods. Values represent the
mean 
 
6
 
 SEM of determinations for four individual lenses.
 
*
 
This value is significantly lower than the corresponding value for
lenses from male rats (
 
P
 
 
 
,
 
0.05 Student’s 
 
t
 
 test).
Figure 2. Influence of ovarian hormones on induction of cataract by TGFb. Ovariectomized rats received vehicle alone (A), estrogen replacement (B),
or progesterone replacement (C). Lenses were cultured with 0.15 ng/ml TGFb2 and photographed after 7 d. Lenses from rats that received vehicle alone
or progesterone developed distinct opacities (A and C), whereas lenses from rats that received estrogen remained transparent (B). Bar, 400 mm.
Table 2. TGFb-induced Opacification in Lenses from 
Ovariectomised Rats on Various Hormone Replacement Regimes
Hormone regime Opacification index
Vehicle alone 240 6 18
Estrogen 0
Progesterone 210 6 19*
TGFb2 (0.15 ng/ml) was used and lenses were cultured for 7 d. The
opacification index was calculated as described in Materials and Meth-
ods. Values represent the mean 6 SEM of determinations for six indi-
vidual lenses.
*This value is not significantly different from the value for controls (ve-
hicle alone).276 Estrogen Protects against TGFb-induced Cataract
posterior capsule towards the posterior pole (Fig. 4 A);
these cells showed reactivity for type I collagen (Fig. 4 C),
but not for a-smooth muscle actin. None of these changes
were observed in lenses from estrogen-treated ovariecto-
mized rats, which remained transparent (Fig. 4, B and D).
In lenses from normal male and female rats (not shown),
concentrations of TGFb .0.15 ng/ml were required to in-
duce changes as pronounced as those in Figs. 3 A and 4 A.
Thus, lenses from normal rats of either sex seemed to be
more resistant to the effects of TGFb than those from ovari-
ectomized rats that did not receive estrogen.
Estrogen administered in vivo as in the above experi-
ments may exert its effects on lens cells directly or indi-
rectly. To determine whether estrogen is capable of influ-
encing lens cells directly, lenses from ovariectomized rats
were treated with estrogen in vitro before and during cul-
ture with TGFb (Table 3). Estrogen-treated lenses showed
negligible opacification in response to TGFb. While a small
region of haziness was observed at the center of some of
these lenses within 6 d of adding TGFb, no tendency to
condense into discrete opacities with time was noted (not
shown). Numerous distinct opacities developed in corre-
sponding lenses cultured in parallel without the addition of
estrogen, which were thus highly susceptible to the catarac-
togenic effects of TGFb under these conditions (Table 3).
Discussion
The present study grew out of our findings that TGFb
induces lens epithelial explants and cultured lenses to un-
dergo molecular and morphological changes that are typi-
cally associated with human subcapsular cataracts (8–10,
16). Both TGFb1 and TGFb2 induce cataractous changes,
TGFb2 being the more potent isoform (16). The catarac-
togenic effects of TGFb are blocked by a pan-specific anti-
body against TGFb (17), and are not simply a “growth fac-
tor” effect. Weanling lenses cultured with another growth
factor, FGF-2 (or FGF-1), at concentrations known to in-
duce lens cell proliferation and/or fiber differentiation (18)
remain transparent (Hales, A., C. Chamberlain, J. McAvoy,
unpublished data).
In cultured lenses from weanling rats, opacities induced
by TGFb correspond with subcapsular plaques of aberrant
cells including spindle-shaped cells which are often associ-
ated with wrinkling of the lens capsule. Abnormal extracel-
lular matrix deposition also occurs, mainly in the plaques.
All these changes are typical of anterior and posterior sub-
capsular cataract and aftercataract (19–22). In addition, TGFb
induces the accumulation of a-smooth muscle actin and
type I collagen in both explants and cultured lenses (9, 10).
These proteins, which are not generally found in the lens,
are present in human anterior subcapsular cataract and in
Figure 3. Histology and im-
munolocalization of cataract
markers. Lenses from ovariecto-
mized rats that received vehicle
alone (A, C, and E) or estrogen
replacement (B, D, and F) were
cultured with 0.15 ng/ml
TGFb2 and fixed at the end of a
7 d culture period. Serial sections
were stained with haematoxylin
and eosin (A and B), or used for
localization of a-smooth muscle
actin (C and D) and type I col-
lagen (E and F). Lenses from rats
that received vehicle alone de-
veloped large anterior subcapsu-
lar plaques (A), which contained
spindle-shaped cells (arrow) and
many condensed nuclei. In addi-
tion, the fiber cells around the
plaques appeared swollen and
vacuoles were commonly present
(asterisk). a-Smooth muscle ac-
tin (C) and type I collagen (E)
were localized within the TGFb-
induced subcapsular plaques and
also in some of the cells that re-
mained attached to the capsule
(arrowheads). Lenses from rats that
received estrogen retained nor-
mal lens morphology (B) with a
monolayer of epithelial cells (ep)
adjacent to the lens capsule (ca)
and overlying the fibre cells (fc).
These lenses showed no reactivity
for either a-smooth muscle actin
(D) or type I collagen (F). Bar,
40 mm.277 Hales et al.
aftercataract (23–26). The present study shows that in
lenses from adult rats, as for weanlings, TGFb induces
opacities with morphological and molecular features of cat-
aract. In each case, the plaques associated with the opacities
are morphologically indistinguishable from early stage hu-
man anterior subcapsular cataracts (11).
Major findings of the present study are that the ovarian hor-
mone, estrogen, protects rat lenses against TGFb-induced
cataract, and that susceptibility to the cataractous changes
induced by TGFb is sex dependent. Culturing lenses from
ovariectomized females with TGFb resulted in marked
opacification of the lens. Estrogen replacement in vivo pre-
vented this response, but progesterone replacement did not
(Table 2; Fig. 2). Furthermore, lenses from male rats were
found to be more susceptible to the cataractogenic effects
of TGFb than those from normal females (Table 1; Fig. 1),
and lenses from normal rats of either sex seemed more re-
sistant to the effects of TGFb than those from ovariecto-
mized rats (Tables 1 and 2). The latter results are also con-
sistent with a protective role for estrogen since circulating
estrogens are present in male rats, albeit at much lower lev-
els than in normal females (27), but not in ovariectomized
females (28). Further support comes from a recent study in-
volving transgenic mice. Females expressing a mutant,
“nonresponsive” estrogen receptor progressively develop
cortical and nuclear cataracts (29). It seems unlikely that the
greater susceptibility of male rats to the cataractogenic ef-
fects of TGFb is due to the presence of testosterone since,
in aging males, cataract increases (5) while testosterone de-
creases (30).
Sex-dependent and estrogen-related differences in sus-
ceptibility to cataract formation, consistent with a protec-
tive role for estrogen, have been noted in epidemiological
studies. After menopause, the prevalence of cortical cata-
racts in females suddenly increases relative to males of
equivalent age (2, 3). Before menopause, the prevalence of
cataract seems to be similar in males and females (3, 31). In
addition, the prevalence and severity of certain forms of
cataract is lower in postmenopausal women on hormone
replacement therapy involving administration of estrogen
with or without progesterone, than in those who are not
undergoing hormone replacement. This is true whether
menopause occurs naturally or as a result of hysterectomy
(5–7). Delayed menopause also seems to protect against
cataract (5–7). Cernea et al. have suggested a possible link
between presenile cataract development and ovarian hor-
mone insufficiency (32). Furthermore, analysis of the age of
patients who undergo cataract surgery indicates that men
tend to develop presenile cataracts approximately four years
earlier than women (2). The present study of cultured rat
lenses provides strong support for this epidemiological evi-
dence that estrogen protects against cataract.
This study goes beyond previous studies, however, in that
it provides direct evidence that estrogen protects against
cataract. Furthermore, it shows that estrogen does so by
protecting lens cells against the cataractogenic effects of
TGFb. This protective effect is observed whether estrogen
is administered in vivo or in vitro. Thus, it seems likely that
estrogen confers protection against cataract by targeting
Figure 4. Posterior migration of cells associated with induction of cata-
ract by TGFb. Lenses from ovariectomized rats that received vehicle
alone (A and C) or estrogen replacement (B and D) were cultured with
0.15 ng/ml TGFb2 and fixed at the end of the 7 d culture period. Serial
sections were stained for routine histology with haematoxylin and eosin
(A and B) or used for immunofluorescent localization of type I collagen
(C and D). The lens equator is positioned at the top of each micrograph.
In lenses from rats that received vehicle alone (A), nucleated cells were
observed migrating along the lens capsule toward the posterior pole (A,
arrowheads). Strong reactivity for type I collagen was associated with these
posteriorly migrating cells (C, arrowheads). In contrast, lenses from rats that
received estrogen replacement maintained a normal lens morphology
with no abnormal migration of cells below the lens equator (B). No reac-
tivity for type I collagen was observed (D). Bar, 40 mm.
Table 3. Effect of Estrogen Exposure In Vitro on TGFb-induced 
Opacification of Lenses from Ovariectomized Rats
Treatment Opacification index
17-b-estradiol 0
No estradiol 151 6 19
Lenses from ovariectomized rats were precultured for 2 d with or with-
out 10210 M 17-b-estradiol, as indicated. Medium was then replaced
(with or without estradiol, as before) and TGFb2 (0.15 ng/ml) was
added immediately. After a further 7 d culture, the opacification index
was determined as described in Materials and Methods. Values represent
the mean 6 SEM of determinations for three individual lenses.278 Estrogen Protects against TGFb-induced Cataract
lens cells directly when administered in vivo, although the
possibility of additional indirect benefits is not excluded. In
other cellular systems, estrogen has been shown to have a
variety of effects on TGFb. It may suppress the effects of
TGFb. For example, estrogen-induced tumorigenesis in
the anterior pituitary of rats is accompanied by a loss of sen-
sitivity to TGFb1 in tumor cells and downregulation of the
TGFb type II receptor (33). Similarly, treating rats with es-
trogen in vivo reduces TGFb binding in the uterus, possi-
bly via downregulation of TGFb receptors (34). On the
other hand, estrogen may enhance TGFb activity when in-
cluded in vitro (35, 36) or have no effect (37).
The present study adds weight to an increasing body of
evidence that hormone replacement therapy not only re-
lieves acute menopausal symptoms, but also offers protec-
tion against various diseases (38). These include cardiovas-
cular diseases such as myocardial infarction, atherosclerosis,
and related hypertension and stroke, as well as osteoporosis
and associated fractures (38–41). Ocular pressure decreases
progressively in both women and men, undergoing treat-
ment with estrogen (42). In addition, estrogen use dramati-
cally reduces the risk of idiopathic macular hole formation,
an ocular condition that is more common in untreated post-
menopausal women than in men of the same age (43).
Many postmenopausal women are now receiving estrogen
replacement therapy, in conjunction with progesterone
where appropriate, but it is not universally advocated or
available. In 1994, it was reported that only 5–10% of
menopausal women in the United States were receiving
this treatment (38).
The opacities that form in rat lenses cultured with TGFb
are anterior subcapsular cataracts. Marked similarities be-
tween TGFb-induced cataract and aftercataract have al-
ready been noted (8, 10). Evidence of subtle changes typi-
cal of posterior subcapsular cataract and cortical cataract is
provided by the present study. We report for the first time
that TGFb can induce migration of aberrant cells along the
lens capsule towards the posterior pole (as in Fig. 4 A). A
similar abnormal migration of nucleated cells along the
posterior capsule is thought to be the basis of human poste-
rior subcapsular cataract formation (20). Some evidence of
TGFb-induced cataract-like change was also observed in
the cortical fibers in the present study (Fig. 3 A).
TGFb is potentially available to lens cells in situ. TGFb
and its mRNA have both been detected in the mammalian
eye (44–46), and biologically active TGFb has been found
in samples of the ocular media that bathe the lens obtained
from human patients suffering from cataract (47–50). Large
reservoirs of inactive TGFb are present in the ocular media
(47, 49, 51, 52) which may become activated, e.g., after
eye surgery (53). It is not clear what level of TGFb stimu-
lation lens cells receive under normal conditions in situ,
and little is known about factors that regulate its activity in
the eye (17). Estrogens have been detected in the ocular
media in untreated female and male rabbits, but it is not
clear what levels of active hormone are present (27).
The present study provides further evidence that TGFb
is involved in the aetiology of various forms of subcapsular
cataract, and possibly cortical cataract. Our finding that es-
trogen, administered in vivo or in vitro, protects against
cataract is consistent with epidemiological studies. Thus, as
suggested by previous studies from this laboratory, the rat
lens model appears to be a valid tool for investigating fac-
tors that influence cataractogenesis. The parallel between
estrogen effects in the rat system and epidemiological evi-
dence also raises the possibility that estrogen may provide
protection against human cataract by influencing a TGFb-
mediated mechanism of cataractogenesis. This study repre-
sents another significant step towards elucidating the mo-
lecular basis of cataract, the foundation for developing new
strategies for prevention or treatment of this debilitating
disease.
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